IsoPlexis Corp·4

Apr 4, 9:23 AM ET

Zhou Jing 4

4 · IsoPlexis Corp · Filed Apr 4, 2022

Insider Transaction Report

Form 4
Period: 2022-03-31
Zhou Jing
Chief Scientific Officer
Transactions
  • Award

    Stock Option

    2022-03-31+73,50073,500 total
    Exercise: $3.43Exp: 2032-03-31Common Stock (73,500 underlying)
Footnotes (1)
  • [F1]Vests 25% on first anniversary of grant date and thereafter in 36 equal monthly installments.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES